Virax Biolabs Group Ltd Income Tax Expense Continuing Operations
Virax Biolabs Group Ltd (VRAX) reported Income Tax Expense Continuing Operations of -$136.66 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2025-07-02
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2025-03-31 | -$136.66K 20-F · filed 2025-07-02 |